TAG ARCHIVES FOR NIH

16
Jun2017

This week’s Research Ethics Roundup looks at the latest US Department of Agriculture (USDA) numbers on animals living in research labs, how researchers are working to better engage diverse populations, President Trump’s decision to keep Dr. Francis Collins as director of the National Institutes of Health (NIH), and the International Committee of Medical Journal Editors (ICMJE)’s final policy on data sharing statements for clinical trials. Read more

1
Jun2017

As the biomedical research enterprise increasingly moves to a more participatory model of research, where research participants are treated more as partners than passive subjects, we can expect greater emphasis on returning individual-level results of research to participants. A prominent example is the All of Us Research Program. Read more

7
Apr2017

This week’s Research Ethics Roundup reviews how experts think data sharing can be accelerated with data authorship attribution, how southern Africa’s San people are combatting exploitative research, the President’s plan for National Institutes of Health (NIH) grants, and a better way to transport laboratory mice. Read more

27
Mar2017

This week’s Research Ethics Roundup examines why legal experts are advising against voluntary compliance of Common Rule changes, President Trump’s plan for the National Institutes of Health (NIH)’s budget, the debate over whether technology can replace animal models in research, and the reaction to President Trump’s pick for Food and Drug Administration (FDA) Commissioner. Read more

30
Jan2017

On January 18, 2017, the final rule from the Department of Health and Human Services (HHS) and the National Institute of Health (NIH)’s corresponding policy on reporting to ClinicalTrials.gov will take effect. ClinicalTrials.gov, which is run by NIH, is a searchable registry of clinical trials. It is a federal requirement that sponsors of certain clinical studies that either have one American research site or are conducted under an investigational device exemption (IDE) or an investigational new drug (IND) application register and report the summary results on ClinicalTrials.gov. However, currently very few pharmaceutical companies, academic institutions, and government agencies are complying with the requirement. The regulatory changes taking effect will only have a meaningful impact if the incoming Administration chooses to enforce them. Read more

Page 1 of 812345...Last »